Monday, 18 October 2010

MS drug alemtuzumab ‘can slow disability progression’

From the MS Society:

New evidence announced today shows that MS drug alemutuzamab can slow down the progression of disability in MS patients and reduce relapse rates for people with relapsing remitting MS over a five year period.  Read more here.